Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

ArQule Inc. (ARQL)

   0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
Arqule Inc is a biopharmaceutical company, engaged in the research and development of therapeutics to treat cancers and rare diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.982 - 8.014 8.014 - 8.047
Low: 7.583 - 7.615 7.615 - 7.649
Close: 7.835 - 7.893 7.893 - 7.953

Technical analysis

as of: 2019-11-12 4:25:47 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 10.59     One year: 12.09
Support: Support1: 6.98    Support2: 5.81
Resistance: Resistance1: 9.06    Resistance2: 10.35
Pivot: 9.00
Moving Average: MA(5): 7.77     MA(20): 9.08
MA(100): 9.26     MA(250): 6.60
MACD: MACD(12,26): -0.18     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 22.85     %D(3): 21.96
RSI: RSI(14): 40.41
52-week: High: 12.22  Low: 2.23  Change(%): 115.0
Average Vol(K): 3-Month: 213329  10-Days: 274251

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ARQL has closed above bottom band by 20.0%. Bollinger Bands are 62.1% wider than normal. The large width of the bands suggest high volatility as compared to ARQL's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Tue, 12 Nov 2019 20:19:21 +0000
Notable Tuesday Option Activity: JPM, MTSI, ARQL

Tue, 10 Sep 2019 05:36:42 +0000
5 Top Losers In Healthcare Sector (NTRP, AKRO, SAVA...)

Thu, 05 Sep 2019 19:23:17 +0000
Noteworthy Thursday Option Activity: ARQL, S, ANTM

Fri, 12 Jul 2019 11:15:00 +0000
5 Best Biotech Stocks of 2019 So Far

Mon, 01 Jul 2019 17:37:41 +0000
Monday 7/1 Insider Buying Report: ARQL, MAC

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 120.73
Shares Float (M) 93.51
% Held by Insiders 1.74
% Held by Institutions 81.20
Shares Short (K) 13220
Shares Short P. Month (K)

Stock Financials

EPS -0.340
Book Value (p.s.) 1.270
PEG Ratio -2.64
Profit Margin
Operating Margin -800.90
Return on Assets (ttm) -16.3
Return on Equity (ttm) -32.1
Qtrly Rev. Growth -95.8
Gross Profit (p.s.) -0.024
Sales Per Share
EBITDA (p.s.) -0.316
Qtrly Earnings Growth
Operating Cash Flow (M) -29.41
Levered Free Cash Flow (M) -17.07

Stock Valuations

P/E -23.21
P/E Growth Ratio 0.02
P/BV 6.21
P/S 197.25
P/CF -32.39

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.